RISK11 signature scores for the biomarker-guided tuberculosis preventive therapy (CORTIS) randomised controlled trial

Scriba, TJ; Fiore-Gartland, A; Penn-Nicholson, A; Mulenga, H; Kimbung Mbandi, S; Borate, B; Mendelsohn, SC; Hadley, K; Hikuam, C; Kaskar, M; Musvosvi, M; Bilek, N; Self, S; Sumner, TORCID logo; White, RGORCID logo; Erasmus, M; Jaxa, L; Raphela, R; Innes, C; Brumskine, W; Hiemstra, A; Malherbe, ST; Hassan-Moosa, R; Tameris, M; Walzl, G; Naidoo, K; Churchyard, G and Hatherill, M (2021). RISK11 signature scores for the biomarker-guided tuberculosis preventive therapy (CORTIS) randomised controlled trial. [Dataset]. University of Cape Town. https://doi.org/10.25375/uct.13573337.v1
Copy

RISK11 transcriptomic signature scores for 20,207 volunteers who were screened at five geographically diverse sites across South Africa. Signature scores were computed from QC'ed gene expression measurements performed by microfluidic RT-qPCR on mRNA derived from whole blood collected in PAXgene tubes. Participants were randomised into three groups and followed-up for 15 months to evaluate diagnostic and prognostic performance of RISK11 and to evaluate efficacy of high-dose isoniazid and rifapentine for prevention of incident TB.

Keywords

Biomarker; Tuberculosis

No files available. Please consult associated links.


EndNote BibTeX Reference Manager Refer Atom Dublin Core (with Type as Type) JSON Multiline CSV Data Cite XML OpenURL ContextObject Simple Metadata MPEG-21 DIDL METS RDF+XML HTML Citation MODS OpenURL ContextObject in Span RDF+N-Triples OPENAIRE EP3 XML RDF+N3 ASCII Citation
Export